OVERVIEW
The Global Antibody Production Market is projected to reach USD 16.46 billion, growing at a CAGR of 14.11% during the forecast period 2019-2024. The improved approval rate of therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are driving the overall market.
TABLE OF CONTENT
1 Global Antibody Production Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Antibody Production Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends By Type of Application
3.3 Key Trends segmented by Geography
4 Global Antibody Production Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Antibody Production Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Antibody Production Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Antibody Production Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Antibody Production Market – By Process (Market Size – & million/billion)
8.1 Filtration
8.2 Upstream Processing
8.3 Downstream Processing
8.4 Multimodal Chromatography Resins
8.5 Ion Exchange (IEX) Chromatography Resins
8.6 Hydrophobic Interaction Chromatography (HIC) Resins
9 Global Antibody Production Market – By End User
9.1 Pharmaceutical and Biotechnology Companies
9.2 Diagnostic Laboratories
9.3 Research Institutes
10 Global Antibody Production Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Antibody Production Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Antibody Production Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 GE Healthcare
12.3 Thermo Fisher Scientific, Inc.
12.4 Merck KGAA
12.5 Integra Biosciences AG
12.6 Fibercell Systems Inc.
12.7 Sartorius AG
12.8 Eppendorf AG
12.9 Cellab GmbH
12.10 Pall Corporation
12.11 Sigma-Aldrich Corporation
12.12 Company 11 & more
13 Global Antibody Production Market – Appendix
13.1 Sources
13.2 Abbreviations